Home › NDC Lookup › Ingredients › Sodium Chloride › 73492-0281-04
SALINE NASAL SODIUM CHLORIDE 6.5 mg/mL Spray, 44 mL — NDC 73492-0281-04 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

SALINE NASAL SODIUM CHLORIDE 6.5 mg/mL Spray, 44 mL — NDC 73492-281-04 (Billing 73492-0281-04)

by ALAINA HEALTHCARE PRIVATE LIMITED · 44 mL in 1 BOTTLE, SPRAY

This is a package of 44 mL of SALINE NASAL SODIUM CHLORIDE 6.5 mg/mL Spray from ALAINA HEALTHCARE PRIVATE LIMITED, marketed since Jun 2026 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 73492-0281-04
🏷️ FDA NDC (as labeled) 73492-281-04 billing pads the product segment with a zero
This package
Contains44 mL Pack sizes2 compare ↓
Main listing for product 73492-281 · Also comes in: 90 ml 73492-281-09
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 73492-281-04 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
73492 labeler · 281 product · 04 package
Package marketed since
Jun 19, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 7349228104 3
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Sodium Chloride (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class I · Aug 19, 2026 — Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene (B BRAUN MEDICAL INC) · FDA recall D-0869-2026
Class I · Aug 17, 2026 — Presence of particulate matter: Particulates identified as fiberglass (Baxter Healthcare Corporation) · FDA recall D-0849-2026
Class II · Apr 2, 2026 — Lack of Assurance of Sterility (Huons Co., Ltd.) · FDA recall D-0531-2026
Class II · Mar 11, 2026 — Lack of Assurance of Sterility (Fresenius Kabi USA, LLC) · FDA recall D-0427-2026
Class II · Mar 11, 2026 — Lack of Assurance of Sterility (Fresenius Kabi USA, LLC) · FDA recall D-0424-2026
Class II · Mar 11, 2026 — Lack of Assurance of Sterility (Fresenius Kabi USA, LLC) · FDA recall D-0432-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 73492-281-04
Product NDC 73492-281
11-digit billing NDC 73492028104
RxCUI 707251
UNII 451W47IQ8X
Application # M022
SPL Set ID ed30a7f9-7132-42da-9bed-63a9b1c80ab2
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-06-19
Route NASAL
Dosage form SPRAY
Substance SODIUM CHLORIDE
Quick answers
  • RxCUI (RxNorm): 707251
Why two NDCs? The FDA registers this code as 73492-281-04 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73492-0281-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Sodium class.

Drug family (ATC) Sodium, Salt solutions, Electrolyte solutions
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. IV forms replace fluid and salt, while injection diluents dissolve other drugs. Other forms are used for rinsing, nasal congestion and nasal care, or to...
  • Follow the directions on your product. Many are used as often as needed by adults and children 4 and over. Do not share the bottle, because that can spread infection.
  • Some people get fever, irritation or infection at the IV site, or too much fluid in the body. Tell your nurse right away if the IV site hurts or looks red.
  • What side effects should I expect with IV sodium chloride?
📖 Read our full Sodium Chloride guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 90 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
73492-0281-04 You're viewing this Main listing 44 mL in 1 BOTTLE, SPRAY 2026-06-19 — Active
73492-0281-09 73492-281-09 90 mL in 1 BOTTLE, SPRAY 2026-07-06 — Active

You're viewing the smallest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 44 mL — 44 ml in 1 bottle, spray.
How does this package differ from NDC 73492-0281-09?
Both are SALINE NASAL SODIUM CHLORIDE 6.5 mg/mL Spray — the drug itself is identical. This page's package is the 44 mL one, while NDC 73492-0281-09 is the 90 ml package.
What NDC number is used to bill for this package of SALINE NASAL SODIUM CHLORIDE 6.5 mg/mL Spray?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Walgreens Saline 6.5 mg/mL 00363-7040-30 WALGREEN 1 bottle — — FDA listed —
Walgreen Saline 6.5 mg/mL 00363-7590-30 WALGREENS 1 bottle — — FDA listed —
HEB Saline 6.5 mg/mL 37808-0845-88 HEB 1 bottle — — FDA listed —
Saline 6.5 mg/mL 37835-0998-01 Bi-Mart 1 bottle — — FDA listed —
KROGER Saline 6.5 mg/mL 41226-0759-30 KROGER 1 bottle — — FDA listed —
MEIJER Saline 6.5 mg/mL 41250-0636-30 MEIJER 1 bottle — — FDA listed —
Saline 6.5 mg/mL 41415-0477-30 PUBLIX 1 bottle — — FDA listed —
Saline 6.5 mg/mL 55319-0047-15 FAMILY 1 bottle — — FDA listed —
Saline 6.5 mg/mL 57896-0333-45 GERI-CARE 44 ml — — FDA listed —
Saline 6.5 mg/mL 63941-0704-15 BEST 1 bottle — — FDA listed —
Family Care Saline 6.5 mg/mL 65923-0493-44 United 44 ml — — FDA listed —
WinCo Foods Saline Nasal Relief .65 g/100mL 67091-0327-46 WinCo 45 ml — — FDA listed —
Saline 6.5 mg/mL 68163-0704-15 Raritan 1 bottle — — FDA listed —
CVS Saline 6.5 mg/mL 69842-0438-30 CVS 1 bottle — — FDA listed —
Saline Nasal 6.5 mg/mLthis 73492-0281-04 ALAINA 44 ml — — FDA listed —
Equate Premium Saline .65 g/100mL 79903-0275-03 Walmart 88 ml — — FDA listed —
Walmart Saline 6.5 mg/mL 79903-0304-30 WALMART 1 bottle — — FDA listed —
Wild Horse 777 Moisturizing Nasal 6.5 mg/mL 80771-0000-15 Wild 1 bottle — — FDA listed —
Quality Choice Saline 6.5 mg/mL 83324-0227-15 QUALITY 1 bottle — — FDA listed —
Quality Choice Saline 6.5 mg/mL 83324-0341-30 QUALITY 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jun 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Sodium Chloride inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII F5UM2KM3W7
    Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
  • UNII 22ADO53M6F
    A mineral salt derived from phosphoric acid, used as a buffer to maintain the pH balance of the medication and help stabilize the active ingredients.
  • UNII KH7I04HPUU
    A salt compound made from sodium and phosphoric acid, used as a buffer to help maintain a stable pH level in the medicine, and sometimes as a binder or filler in tablets and capsules.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzalkonium chloride, disodium hydrogen phosphate anhydrous, purified water, sodium acid phosphate.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerALAINA HEALTHCARE PRIVATE LIMITED
FDA applicationM022 (OTC MONOGRAPH DRUG)
Labeler code73492
First marketedJun 2026
Product typeHuman Otc Drug
Portfolio16 products on file

More NDCs from ALAINA HEALTHCARE PRIVATE LIMITED labeler code 73492

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 28 words ▾

Uses provides moisture to dry nasal passages helps relieve dry, irritated nasal passages due to colds, allergies, dry air, pollution, smoke, air travel, and use of decongestants/steroidal sprays.

⏱️ Dosage and Administration 51 words ▾

Directions The use of this dispenser by more than one person may spread infection. Hold bottle upright for spray, horizontally for stream, and upside down for drop. For children and adults, squeeze bottle twice in each nostril, as often as needed, or as directed by doctor. For infants, use drop application.

⚠️ Warnings 13 words ▾

Warnings If pregnant or breast feeding , ask a health professional before use.

🧪 Active Ingredient 5 words ▾

Active ingredient Sodium Chloride 0.65%

🧪 Inactive Ingredients 13 words ▾

Inactive ingredients benzalkonium chloride, disodium hydrogen phosphate anhydrous, purified water, sodium acid phosphate.

🎯 Purpose 2 words ▾

Purpose Moisturizer

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 6 words ▾

Other information: store at room temperature

📄 Questions or Comments 3 words ▾

Questions or comments?

📄 Package Label / Principal Display Panel 69 words ▾

PRINCIPAL DISPLAY PANEL Saline Nasal Spray Sodium Chloride 0.65% Relieves dry nasal passages Soothes dry, stuffy noses Safe for frequent daily use Compare to active ingredients in OCEAN ®

1.5FL OZ (44 mL) Saline Nasal Spray Sodium Chloride 0.65% Relieves dry nasal passages Soothes dry, stuffy noses Safe for frequent daily use Compare to active ingredients in OCEAN ® 3 FL OZ (90 mL) "Image Description" "Image Description"

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Sodium Chloride (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Sodium Chloride. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$16.2K
Claims incl. refills
266
Beneficiaries
53
Spend / beneficiary
$304.99
Spend / claim
$60.77
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for SALINE NASAL (this brand).

Top reported reactions

Nausea5,260
Myelosuppression5,168
Dyspnoea4,606
Headache4,261
Pyrexia4,195
Fatigue4,061
Vomiting3,746

Age at onset

Neonate122
Infant128
Child819
Adolescent624
Adult8,743
Elderly4,774

Reporter sex

73,203 reports
Male · 42%
Female · 58%
Unknown · 0%

Serious outcomes

Hospitalization33,232
Death6,308
Life-threatening4,972
Disabling1,666
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 9,882 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by ALAINA HEALTHCARE PRIVATE LIMITED. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 90 ml (73492-0281-09). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
ALAINA HEALTHCARE PRIVATE LIMITED is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 73492-0273-60 · ALAINA 73492-0291-28 · ALAINA →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.